1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Reetoo

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2017

Location

Shenzhen Guangdong China

Primary Industry

Medical Devices & Equipment

About

Established in 2017 and based in Shenzhen, China, Reetoo is a medical equipment company that focuses on the research, development, and production of AI testing equipment. It has 14,000 square meters of R&D center and production basement, with more than 400 patents. In 2018, the company finished its first production plant. In 2022, it was recognized as a National High-tech Enterprise. In December 2023, Reetoo raised a series B2 funding for over CNY 100 million. The company's products are AI testing instruments and equipment for 8 categories, including blood, leukorrhea, semen, chromosomes, urine, feces, sputum, and tissues. The products use DeepCell engine, AI vision, AI recognition system, and other technologies. Its products have covered more than 1,500 hospitals across the country. The company will use the funding to accelerate the marketization of AI testing labs.
Current Investors
Legend Star, CAS Investment Management, Shenzhen Investment Holdings

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors, Diagnostic Equipment
Website
www.reetoo.com
Verticals
Artificial Intelligence, Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.